Suspecting Pulmonary Hypertension in the Dyspneic Patient: Who, When, and How

Feb 24, 2021 06:30pm -
Feb 24, 2021 07:30pm

Event Description



A Meeting of the New Jersey Association of Osteopathic Physicians and Surgeons


Suspecting Pulmonary Hypertension in the Dyspneic Patient:

Who, When, and How


Wednesday, February 24, 2021

6:30 – 7:30 pm est Webinar



K. Akaya Smith, MD

Assistant Professor of Clinical Medicine

Perelman School of Medicine at the

University of Pennsylvania

Medical Director, Pulmonary

Hypertension Program

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania



Zoom Link:


Educational Objectives

This CME program is designed to improve competence,

performance, and patient care practices by instructing

clinicians in the highest quality of care for patients with

PAH. At the conclusion of this program, participants will

be able to:

n Accurately diagnose patients through comprehensive

screening and early recognition of symptoms

n Evaluate the patient’s condition and prescribe

optimal long-term management, including knowing

when and how to treat and when to consult with

colleagues at an established PAH center


Target Audience

This activity has been designed for pulmonologists,

cardiologists, rheumatologists, internists, and

primary care physicians, as well as nurses, physician

assistants, and other allied health professionals

who help care for patients with pulmonary arterial

hypertension (PAH).



In support of improving patient

care, this activity has been planned

and implemented by Washington

University School of Medicine in

St. Louis, Continuing Medical

Education and the Pulmonary Hypertension Association.

Washington University School of Medicine in St. Louis

is jointly accredited by the Accreditation Council for

Continuing Medical Education (ACCME), the Accreditation

Council for Pharmacy Education (ACPE), and the American

Nurses Credentialing Center (ANCC), to provide continuing

education for the healthcare team.


Credit Awarded for This Activity

Washington University School of Medicine in St. Louis

designates this internet live activity for a maximum of

1 AMA PRA Category 1 CreditTM. Physicians should claim

only the credit commensurate with the extent of their

participation in the activity



This activity is supported by educational grants from:

Platinum Level Gold Level

Janssen Pharmaceuticals, Inc. United Therapeutics Corporation

Event Type:Webinar
Category:Educational Seminar
Early registration ends on Feb 01, 2021.
Regular registration starts on Feb 02, 2021 and ends on Feb 24, 2021.
Late registration starts on Feb 25, 2021.
(GMT-05:00) Eastern Time (US & Canada)